We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$263M
AUM Growth
-$4.57M
Cap. Flow
-$26.4M
Cap. Flow %
-10.06%
Top 10 Hldgs %
61.7%
Holding
188
New
48
Increased
23
Reduced
30
Closed
62

Top Sells

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$2.72M
2
MU icon
Micron Technology
MU
+$2.21M
3
OA
Orbital ATK, Inc.
OA
+$1.98M
4
MON
Monsanto Co
MON
+$1.84M
5
XOM icon
ExxonMobil
XOM
+$1.74M

Sector Composition

Rank Sector Weight
1 Miscellaneous 81.49%
2 Healthcare 8.46%
3 Financials 2.89%
4 Technology 2.49%
5 Industrials 1.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STML
101
DELISTED
Stemline Therapeutics, Inc.
STML
$193K 0.07%
12,050
-6,450
-35% -$115K
VIRX
102
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$192K 0.07%
2,594
-2,406
-48% -$214K
ENLK
103
DELISTED
EnLink Midstream Partners, LP
ENLK
$175K 0.07%
+11,262
New +$174K
NAVI icon
104
Navient
NAVI
$887M
$165K 0.06%
+12,700
New +$173K
MTVA
105
MetaVia Inc
MTVA
$11.2M
-1
Closed -$408K
ACHN
106
DELISTED
Achillion Pharmaceuticals
ACHN
$137K 0.05%
48,305
-51,695
-52% -$176K
GE icon
107
CALL
GE Aerospace
GE
$355B
$136K 0.05%
2,087
SRRA
108
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$135K 0.05%
1,138
-1,362
-54% -$137K
GDP
109
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$130K 0.05%
10,500
-7,000
-40% -$88.9K
CLDX icon
110
Celldex Therapeutics
CLDX
$3.07B
$127K 0.05%
+16,820
New +$225K
DCOY
111
Decoy Therapeutics
DCOY
$1.9M
0
AUD
112
DELISTED
Audacy, Inc.
AUD
$99K 0.04%
13,171
-300
-2% -$2.54K
AGI icon
113
Alamos Gold
AGI
$15.4B
$84K 0.03%
14,825
CRIS icon
114
Curis
CRIS
$3.61M
$81K 0.03%
118
-25
-17% -$25.6K
RAD
115
DELISTED
Rite Aid Corporation
RAD
$74K 0.03%
2,150
-2,500
-54% -$84.8K
ABBV icon
116
AbbVie
ABBV
$451B
-5,597
Closed -$530K
ABUS icon
117
Arbutus Biopharma
ABUS
$1B
-45,000
Closed -$225K
ALNY icon
118
Alnylam Pharmaceuticals
ALNY
$31.7B
-2,500
Closed -$248K
AMZN icon
119
Amazon
AMZN
$2.87T
-3,480
Closed -$252K
AN icon
120
AutoNation
AN
$6.62B
-5,445
Closed -$255K
ANET icon
121
Arista Networks
ANET
$246B
-23,696
Closed -$378K
ATI icon
122
ATI
ATI
$28.7B
-10,871
Closed -$257K
AZN icon
123
CALL
AstraZeneca
AZN
$252B
-12,500
Closed -$874K
CNP icon
124
CenterPoint Energy
CNP
$25.8B
-9,100
Closed -$249K
DIS icon
125
PUT
Walt Disney
DIS
$187B
-15,000
Closed -$1.51M

Similar funds

Telemetry Investments's Q2 2018 Portfolio in Review

As of Q2 2018, Telemetry Investments held 188 positions worth $263M, down 1.7% from $267M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Telemetry Investments withdrew a net $26.4M in Q2 2018, closing 62 positions and reducing 30 holdings. Its most notable exit was Time Warner Inc, an estimated $2.72M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 81% of assets, up from 77% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Telemetry Investments opened a new position in iShares MSCI Mexico ETF worth $3.54M.

  • Telemetry Investments's largest Q2 2018 buy was iShares MSCI Mexico ETF: 75,000 shares worth $3.54M.
  • Telemetry Investments added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $3.51M increase.
  • Telemetry Investments's biggest Q2 2018 reduction was Rockwell Collins, cutting an estimated $676K.
  • Telemetry Investments fully exited Time Warner Inc in Q2 2018, selling an estimated $2.72M.
  • Telemetry Investments's ten largest holdings make up 62% of its $263M portfolio in Q2 2018.
  • Telemetry Investments opened 48 new positions and closed 62 in Q2 2018.
  • Telemetry Investments's portfolio value fell 1.7% quarter-over-quarter to $263M.

Based on Telemetry Investments's 13F filing for Q2 2018, filed 14 Aug 2018.